UBIO
Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO
Delisted
UBIO was delisted on the 27th of March, 2020.
9 hedge funds and large institutions have $4.17M invested in Proshares UltraPro NASDAQ Biotechnology in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
9
Holding in Top 10
–
Calls
$680K
Puts
–
Top Buyers
| 1 | +$1.78M | |
| 2 | +$422K | |
| 3 | +$310K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$286K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$68K |